img

Global Gene-based Advanced Therapy Medicinal Market Research Report 2024

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Gene-based Advanced Therapy Medicinal Market Research Report 2024

Gene Delivery System or Gene therapy is an experimental technique that uses genes to treat or prevent disease. In the future, this technique may allow doctors to treat a disorder by inserting a gene into a patient's cells instead of using drugs or surgery.
According to Mr Accuracy reports new survey, global Gene-based Advanced Therapy Medicinal market is projected to reach US$ 34850 million in 2029, increasing from US$ 9063 million in 2022, with the CAGR of 20.2% during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Gene-based Advanced Therapy Medicinal market research.
The advanced therapy based on gene market is driven by the potential to revolutionize healthcare by offering personalized and targeted treatments for genetic disorders and other diseases. Advanced therapy based on gene includes gene therapy, cell therapy, and gene editing techniques, which aim to modify or replace faulty genes to treat or cure diseases at the genetic level. The rise in the understanding of genetic mechanisms and advancements in biotechnology and genetic engineering contribute to market growth as these therapies hold promise for previously untreatable conditions. Moreover, increasing investment in research and clinical trials and the support from regulatory agencies for accelerated approval further boost the development and commercialization of advanced gene therapies. However, the market also faces challenges, including the complexity of manufacturing and delivering gene-based therapies, safety concerns related to viral vectors and off-target effects in gene editing, and high treatment costs. Additionally, addressing regulatory requirements and ensuring accessibility and affordability of advanced gene therapies can pose obstacles for broader adoption. To succeed, companies must focus on research and development to advance the safety and efficacy of gene-based therapies, collaborate with healthcare stakeholders to build robust infrastructure, and address the challenges to fully realize the transformative potential of advanced therapy based on gene in modern medicine.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Gene-based Advanced Therapy Medicinal market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Biogen
Novartis
Gilead Sciences
Sarepta Therapeutics
Alnylam Pharmaceuticals
Amgen
Spark Therapeutics
Akcea Therapeutics
Sunway Biotech
SIBIONO
AnGes
Orchard Therapeutics
Human Stem Cells Institute
Segment by Type
Viral Gene Delivery System
Non-viral Gene Delivery System

Segment by Application


Neurological Diseases
Cancer
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Gene-based Advanced Therapy Medicinal report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Gene-based Advanced Therapy Medicinal Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Viral Gene Delivery System
1.2.3 Non-viral Gene Delivery System
1.3 Market by Application
1.3.1 Global Gene-based Advanced Therapy Medicinal Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Neurological Diseases
1.3.3 Cancer
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Gene-based Advanced Therapy Medicinal Market Perspective (2018-2029)
2.2 Gene-based Advanced Therapy Medicinal Growth Trends by Region
2.2.1 Global Gene-based Advanced Therapy Medicinal Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Gene-based Advanced Therapy Medicinal Historic Market Size by Region (2018-2024)
2.2.3 Gene-based Advanced Therapy Medicinal Forecasted Market Size by Region (2024-2029)
2.3 Gene-based Advanced Therapy Medicinal Market Dynamics
2.3.1 Gene-based Advanced Therapy Medicinal Industry Trends
2.3.2 Gene-based Advanced Therapy Medicinal Market Drivers
2.3.3 Gene-based Advanced Therapy Medicinal Market Challenges
2.3.4 Gene-based Advanced Therapy Medicinal Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Gene-based Advanced Therapy Medicinal Players by Revenue
3.1.1 Global Top Gene-based Advanced Therapy Medicinal Players by Revenue (2018-2024)
3.1.2 Global Gene-based Advanced Therapy Medicinal Revenue Market Share by Players (2018-2024)
3.2 Global Gene-based Advanced Therapy Medicinal Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Gene-based Advanced Therapy Medicinal Revenue
3.4 Global Gene-based Advanced Therapy Medicinal Market Concentration Ratio
3.4.1 Global Gene-based Advanced Therapy Medicinal Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Gene-based Advanced Therapy Medicinal Revenue in 2022
3.5 Gene-based Advanced Therapy Medicinal Key Players Head office and Area Served
3.6 Key Players Gene-based Advanced Therapy Medicinal Product Solution and Service
3.7 Date of Enter into Gene-based Advanced Therapy Medicinal Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Gene-based Advanced Therapy Medicinal Breakdown Data by Type
4.1 Global Gene-based Advanced Therapy Medicinal Historic Market Size by Type (2018-2024)
4.2 Global Gene-based Advanced Therapy Medicinal Forecasted Market Size by Type (2024-2029)
5 Gene-based Advanced Therapy Medicinal Breakdown Data by Application
5.1 Global Gene-based Advanced Therapy Medicinal Historic Market Size by Application (2018-2024)
5.2 Global Gene-based Advanced Therapy Medicinal Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Gene-based Advanced Therapy Medicinal Market Size (2018-2029)
6.2 North America Gene-based Advanced Therapy Medicinal Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Gene-based Advanced Therapy Medicinal Market Size by Country (2018-2024)
6.4 North America Gene-based Advanced Therapy Medicinal Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Gene-based Advanced Therapy Medicinal Market Size (2018-2029)
7.2 Europe Gene-based Advanced Therapy Medicinal Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Gene-based Advanced Therapy Medicinal Market Size by Country (2018-2024)
7.4 Europe Gene-based Advanced Therapy Medicinal Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Gene-based Advanced Therapy Medicinal Market Size (2018-2029)
8.2 Asia-Pacific Gene-based Advanced Therapy Medicinal Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Gene-based Advanced Therapy Medicinal Market Size by Region (2018-2024)
8.4 Asia-Pacific Gene-based Advanced Therapy Medicinal Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Gene-based Advanced Therapy Medicinal Market Size (2018-2029)
9.2 Latin America Gene-based Advanced Therapy Medicinal Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Gene-based Advanced Therapy Medicinal Market Size by Country (2018-2024)
9.4 Latin America Gene-based Advanced Therapy Medicinal Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Gene-based Advanced Therapy Medicinal Market Size (2018-2029)
10.2 Middle East & Africa Gene-based Advanced Therapy Medicinal Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Gene-based Advanced Therapy Medicinal Market Size by Country (2018-2024)
10.4 Middle East & Africa Gene-based Advanced Therapy Medicinal Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Biogen
11.1.1 Biogen Company Detail
11.1.2 Biogen Business Overview
11.1.3 Biogen Gene-based Advanced Therapy Medicinal Introduction
11.1.4 Biogen Revenue in Gene-based Advanced Therapy Medicinal Business (2018-2024)
11.1.5 Biogen Recent Development
11.2 Novartis
11.2.1 Novartis Company Detail
11.2.2 Novartis Business Overview
11.2.3 Novartis Gene-based Advanced Therapy Medicinal Introduction
11.2.4 Novartis Revenue in Gene-based Advanced Therapy Medicinal Business (2018-2024)
11.2.5 Novartis Recent Development
11.3 Gilead Sciences
11.3.1 Gilead Sciences Company Detail
11.3.2 Gilead Sciences Business Overview
11.3.3 Gilead Sciences Gene-based Advanced Therapy Medicinal Introduction
11.3.4 Gilead Sciences Revenue in Gene-based Advanced Therapy Medicinal Business (2018-2024)
11.3.5 Gilead Sciences Recent Development
11.4 Sarepta Therapeutics
11.4.1 Sarepta Therapeutics Company Detail
11.4.2 Sarepta Therapeutics Business Overview
11.4.3 Sarepta Therapeutics Gene-based Advanced Therapy Medicinal Introduction
11.4.4 Sarepta Therapeutics Revenue in Gene-based Advanced Therapy Medicinal Business (2018-2024)
11.4.5 Sarepta Therapeutics Recent Development
11.5 Alnylam Pharmaceuticals
11.5.1 Alnylam Pharmaceuticals Company Detail
11.5.2 Alnylam Pharmaceuticals Business Overview
11.5.3 Alnylam Pharmaceuticals Gene-based Advanced Therapy Medicinal Introduction
11.5.4 Alnylam Pharmaceuticals Revenue in Gene-based Advanced Therapy Medicinal Business (2018-2024)
11.5.5 Alnylam Pharmaceuticals Recent Development
11.6 Amgen
11.6.1 Amgen Company Detail
11.6.2 Amgen Business Overview
11.6.3 Amgen Gene-based Advanced Therapy Medicinal Introduction
11.6.4 Amgen Revenue in Gene-based Advanced Therapy Medicinal Business (2018-2024)
11.6.5 Amgen Recent Development
11.7 Spark Therapeutics
11.7.1 Spark Therapeutics Company Detail
11.7.2 Spark Therapeutics Business Overview
11.7.3 Spark Therapeutics Gene-based Advanced Therapy Medicinal Introduction
11.7.4 Spark Therapeutics Revenue in Gene-based Advanced Therapy Medicinal Business (2018-2024)
11.7.5 Spark Therapeutics Recent Development
11.8 Akcea Therapeutics
11.8.1 Akcea Therapeutics Company Detail
11.8.2 Akcea Therapeutics Business Overview
11.8.3 Akcea Therapeutics Gene-based Advanced Therapy Medicinal Introduction
11.8.4 Akcea Therapeutics Revenue in Gene-based Advanced Therapy Medicinal Business (2018-2024)
11.8.5 Akcea Therapeutics Recent Development
11.9 Sunway Biotech
11.9.1 Sunway Biotech Company Detail
11.9.2 Sunway Biotech Business Overview
11.9.3 Sunway Biotech Gene-based Advanced Therapy Medicinal Introduction
11.9.4 Sunway Biotech Revenue in Gene-based Advanced Therapy Medicinal Business (2018-2024)
11.9.5 Sunway Biotech Recent Development
11.10 SIBIONO
11.10.1 SIBIONO Company Detail
11.10.2 SIBIONO Business Overview
11.10.3 SIBIONO Gene-based Advanced Therapy Medicinal Introduction
11.10.4 SIBIONO Revenue in Gene-based Advanced Therapy Medicinal Business (2018-2024)
11.10.5 SIBIONO Recent Development
11.11 AnGes
11.11.1 AnGes Company Detail
11.11.2 AnGes Business Overview
11.11.3 AnGes Gene-based Advanced Therapy Medicinal Introduction
11.11.4 AnGes Revenue in Gene-based Advanced Therapy Medicinal Business (2018-2024)
11.11.5 AnGes Recent Development
11.12 Orchard Therapeutics
11.12.1 Orchard Therapeutics Company Detail
11.12.2 Orchard Therapeutics Business Overview
11.12.3 Orchard Therapeutics Gene-based Advanced Therapy Medicinal Introduction
11.12.4 Orchard Therapeutics Revenue in Gene-based Advanced Therapy Medicinal Business (2018-2024)
11.12.5 Orchard Therapeutics Recent Development
11.13 Human Stem Cells Institute
11.13.1 Human Stem Cells Institute Company Detail
11.13.2 Human Stem Cells Institute Business Overview
11.13.3 Human Stem Cells Institute Gene-based Advanced Therapy Medicinal Introduction
11.13.4 Human Stem Cells Institute Revenue in Gene-based Advanced Therapy Medicinal Business (2018-2024)
11.13.5 Human Stem Cells Institute Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Gene-based Advanced Therapy Medicinal Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Viral Gene Delivery System
Table 3. Key Players of Non-viral Gene Delivery System
Table 4. Global Gene-based Advanced Therapy Medicinal Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 5. Global Gene-based Advanced Therapy Medicinal Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Gene-based Advanced Therapy Medicinal Market Size by Region (2018-2024) & (US$ Million)
Table 7. Global Gene-based Advanced Therapy Medicinal Market Share by Region (2018-2024)
Table 8. Global Gene-based Advanced Therapy Medicinal Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global Gene-based Advanced Therapy Medicinal Market Share by Region (2024-2029)
Table 10. Gene-based Advanced Therapy Medicinal Market Trends
Table 11. Gene-based Advanced Therapy Medicinal Market Drivers
Table 12. Gene-based Advanced Therapy Medicinal Market Challenges
Table 13. Gene-based Advanced Therapy Medicinal Market Restraints
Table 14. Global Gene-based Advanced Therapy Medicinal Revenue by Players (2018-2024) & (US$ Million)
Table 15. Global Gene-based Advanced Therapy Medicinal Market Share by Players (2018-2024)
Table 16. Global Top Gene-based Advanced Therapy Medicinal Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene-based Advanced Therapy Medicinal as of 2022)
Table 17. Ranking of Global Top Gene-based Advanced Therapy Medicinal Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Gene-based Advanced Therapy Medicinal Revenue (CR5 and HHI) & (2018-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Gene-based Advanced Therapy Medicinal Product Solution and Service
Table 21. Date of Enter into Gene-based Advanced Therapy Medicinal Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Gene-based Advanced Therapy Medicinal Market Size by Type (2018-2024) & (US$ Million)
Table 24. Global Gene-based Advanced Therapy Medicinal Revenue Market Share by Type (2018-2024)
Table 25. Global Gene-based Advanced Therapy Medicinal Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global Gene-based Advanced Therapy Medicinal Revenue Market Share by Type (2024-2029)
Table 27. Global Gene-based Advanced Therapy Medicinal Market Size by Application (2018-2024) & (US$ Million)
Table 28. Global Gene-based Advanced Therapy Medicinal Revenue Market Share by Application (2018-2024)
Table 29. Global Gene-based Advanced Therapy Medicinal Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global Gene-based Advanced Therapy Medicinal Revenue Market Share by Application (2024-2029)
Table 31. North America Gene-based Advanced Therapy Medicinal Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 32. North America Gene-based Advanced Therapy Medicinal Market Size by Country (2018-2024) & (US$ Million)
Table 33. North America Gene-based Advanced Therapy Medicinal Market Size by Country (2024-2029) & (US$ Million)
Table 34. Europe Gene-based Advanced Therapy Medicinal Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 35. Europe Gene-based Advanced Therapy Medicinal Market Size by Country (2018-2024) & (US$ Million)
Table 36. Europe Gene-based Advanced Therapy Medicinal Market Size by Country (2024-2029) & (US$ Million)
Table 37. Asia-Pacific Gene-based Advanced Therapy Medicinal Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 38. Asia-Pacific Gene-based Advanced Therapy Medicinal Market Size by Region (2018-2024) & (US$ Million)
Table 39. Asia-Pacific Gene-based Advanced Therapy Medicinal Market Size by Region (2024-2029) & (US$ Million)
Table 40. Latin America Gene-based Advanced Therapy Medicinal Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 41. Latin America Gene-based Advanced Therapy Medicinal Market Size by Country (2018-2024) & (US$ Million)
Table 42. Latin America Gene-based Advanced Therapy Medicinal Market Size by Country (2024-2029) & (US$ Million)
Table 43. Middle East & Africa Gene-based Advanced Therapy Medicinal Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Middle East & Africa Gene-based Advanced Therapy Medicinal Market Size by Country (2018-2024) & (US$ Million)
Table 45. Middle East & Africa Gene-based Advanced Therapy Medicinal Market Size by Country (2024-2029) & (US$ Million)
Table 46. Biogen Company Detail
Table 47. Biogen Business Overview
Table 48. Biogen Gene-based Advanced Therapy Medicinal Product
Table 49. Biogen Revenue in Gene-based Advanced Therapy Medicinal Business (2018-2024) & (US$ Million)
Table 50. Biogen Recent Development
Table 51. Novartis Company Detail
Table 52. Novartis Business Overview
Table 53. Novartis Gene-based Advanced Therapy Medicinal Product
Table 54. Novartis Revenue in Gene-based Advanced Therapy Medicinal Business (2018-2024) & (US$ Million)
Table 55. Novartis Recent Development
Table 56. Gilead Sciences Company Detail
Table 57. Gilead Sciences Business Overview
Table 58. Gilead Sciences Gene-based Advanced Therapy Medicinal Product
Table 59. Gilead Sciences Revenue in Gene-based Advanced Therapy Medicinal Business (2018-2024) & (US$ Million)
Table 60. Gilead Sciences Recent Development
Table 61. Sarepta Therapeutics Company Detail
Table 62. Sarepta Therapeutics Business Overview
Table 63. Sarepta Therapeutics Gene-based Advanced Therapy Medicinal Product
Table 64. Sarepta Therapeutics Revenue in Gene-based Advanced Therapy Medicinal Business (2018-2024) & (US$ Million)
Table 65. Sarepta Therapeutics Recent Development
Table 66. Alnylam Pharmaceuticals Company Detail
Table 67. Alnylam Pharmaceuticals Business Overview
Table 68. Alnylam Pharmaceuticals Gene-based Advanced Therapy Medicinal Product
Table 69. Alnylam Pharmaceuticals Revenue in Gene-based Advanced Therapy Medicinal Business (2018-2024) & (US$ Million)
Table 70. Alnylam Pharmaceuticals Recent Development
Table 71. Amgen Company Detail
Table 72. Amgen Business Overview
Table 73. Amgen Gene-based Advanced Therapy Medicinal Product
Table 74. Amgen Revenue in Gene-based Advanced Therapy Medicinal Business (2018-2024) & (US$ Million)
Table 75. Amgen Recent Development
Table 76. Spark Therapeutics Company Detail
Table 77. Spark Therapeutics Business Overview
Table 78. Spark Therapeutics Gene-based Advanced Therapy Medicinal Product
Table 79. Spark Therapeutics Revenue in Gene-based Advanced Therapy Medicinal Business (2018-2024) & (US$ Million)
Table 80. Spark Therapeutics Recent Development
Table 81. Akcea Therapeutics Company Detail
Table 82. Akcea Therapeutics Business Overview
Table 83. Akcea Therapeutics Gene-based Advanced Therapy Medicinal Product
Table 84. Akcea Therapeutics Revenue in Gene-based Advanced Therapy Medicinal Business (2018-2024) & (US$ Million)
Table 85. Akcea Therapeutics Recent Development
Table 86. Sunway Biotech Company Detail
Table 87. Sunway Biotech Business Overview
Table 88. Sunway Biotech Gene-based Advanced Therapy Medicinal Product
Table 89. Sunway Biotech Revenue in Gene-based Advanced Therapy Medicinal Business (2018-2024) & (US$ Million)
Table 90. Sunway Biotech Recent Development
Table 91. SIBIONO Company Detail
Table 92. SIBIONO Business Overview
Table 93. SIBIONO Gene-based Advanced Therapy Medicinal Product
Table 94. SIBIONO Revenue in Gene-based Advanced Therapy Medicinal Business (2018-2024) & (US$ Million)
Table 95. SIBIONO Recent Development
Table 96. AnGes Company Detail
Table 97. AnGes Business Overview
Table 98. AnGes Gene-based Advanced Therapy Medicinal Product
Table 99. AnGes Revenue in Gene-based Advanced Therapy Medicinal Business (2018-2024) & (US$ Million)
Table 100. AnGes Recent Development
Table 101. Orchard Therapeutics Company Detail
Table 102. Orchard Therapeutics Business Overview
Table 103. Orchard Therapeutics Gene-based Advanced Therapy Medicinal Product
Table 104. Orchard Therapeutics Revenue in Gene-based Advanced Therapy Medicinal Business (2018-2024) & (US$ Million)
Table 105. Orchard Therapeutics Recent Development
Table 106. Human Stem Cells Institute Company Detail
Table 107. Human Stem Cells Institute Business Overview
Table 108. Human Stem Cells Institute Gene-based Advanced Therapy Medicinal Product
Table 109. Human Stem Cells Institute Revenue in Gene-based Advanced Therapy Medicinal Business (2018-2024) & (US$ Million)
Table 110. Human Stem Cells Institute Recent Development
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Gene-based Advanced Therapy Medicinal Market Size Comparison by Type (2024-2029) & (US$ Million)
Figure 2. Global Gene-based Advanced Therapy Medicinal Market Share by Type: 2022 VS 2029
Figure 3. Viral Gene Delivery System Features
Figure 4. Non-viral Gene Delivery System Features
Figure 5. Global Gene-based Advanced Therapy Medicinal Market Size Comparison by Application (2024-2029) & (US$ Million)
Figure 6. Global Gene-based Advanced Therapy Medicinal Market Share by Application: 2022 VS 2029
Figure 7. Neurological Diseases Case Studies
Figure 8. Cancer Case Studies
Figure 9. Other Case Studies
Figure 10. Gene-based Advanced Therapy Medicinal Report Years Considered
Figure 11. Global Gene-based Advanced Therapy Medicinal Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 12. Global Gene-based Advanced Therapy Medicinal Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Gene-based Advanced Therapy Medicinal Market Share by Region: 2022 VS 2029
Figure 14. Global Gene-based Advanced Therapy Medicinal Market Share by Players in 2022
Figure 15. Global Top Gene-based Advanced Therapy Medicinal Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene-based Advanced Therapy Medicinal as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Gene-based Advanced Therapy Medicinal Revenue in 2022
Figure 17. North America Gene-based Advanced Therapy Medicinal Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 18. North America Gene-based Advanced Therapy Medicinal Market Share by Country (2018-2029)
Figure 19. United States Gene-based Advanced Therapy Medicinal Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. Canada Gene-based Advanced Therapy Medicinal Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Europe Gene-based Advanced Therapy Medicinal Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Europe Gene-based Advanced Therapy Medicinal Market Share by Country (2018-2029)
Figure 23. Germany Gene-based Advanced Therapy Medicinal Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. France Gene-based Advanced Therapy Medicinal Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. U.K. Gene-based Advanced Therapy Medicinal Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Italy Gene-based Advanced Therapy Medicinal Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Russia Gene-based Advanced Therapy Medicinal Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Nordic Countries Gene-based Advanced Therapy Medicinal Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Asia-Pacific Gene-based Advanced Therapy Medicinal Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Asia-Pacific Gene-based Advanced Therapy Medicinal Market Share by Region (2018-2029)
Figure 31. China Gene-based Advanced Therapy Medicinal Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Japan Gene-based Advanced Therapy Medicinal Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. South Korea Gene-based Advanced Therapy Medicinal Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Southeast Asia Gene-based Advanced Therapy Medicinal Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. India Gene-based Advanced Therapy Medicinal Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Australia Gene-based Advanced Therapy Medicinal Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Latin America Gene-based Advanced Therapy Medicinal Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Latin America Gene-based Advanced Therapy Medicinal Market Share by Country (2018-2029)
Figure 39. Mexico Gene-based Advanced Therapy Medicinal Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Brazil Gene-based Advanced Therapy Medicinal Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Middle East & Africa Gene-based Advanced Therapy Medicinal Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Middle East & Africa Gene-based Advanced Therapy Medicinal Market Share by Country (2018-2029)
Figure 43. Turkey Gene-based Advanced Therapy Medicinal Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Saudi Arabia Gene-based Advanced Therapy Medicinal Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Biogen Revenue Growth Rate in Gene-based Advanced Therapy Medicinal Business (2018-2024)
Figure 46. Novartis Revenue Growth Rate in Gene-based Advanced Therapy Medicinal Business (2018-2024)
Figure 47. Gilead Sciences Revenue Growth Rate in Gene-based Advanced Therapy Medicinal Business (2018-2024)
Figure 48. Sarepta Therapeutics Revenue Growth Rate in Gene-based Advanced Therapy Medicinal Business (2018-2024)
Figure 49. Alnylam Pharmaceuticals Revenue Growth Rate in Gene-based Advanced Therapy Medicinal Business (2018-2024)
Figure 50. Amgen Revenue Growth Rate in Gene-based Advanced Therapy Medicinal Business (2018-2024)
Figure 51. Spark Therapeutics Revenue Growth Rate in Gene-based Advanced Therapy Medicinal Business (2018-2024)
Figure 52. Akcea Therapeutics Revenue Growth Rate in Gene-based Advanced Therapy Medicinal Business (2018-2024)
Figure 53. Sunway Biotech Revenue Growth Rate in Gene-based Advanced Therapy Medicinal Business (2018-2024)
Figure 54. SIBIONO Revenue Growth Rate in Gene-based Advanced Therapy Medicinal Business (2018-2024)
Figure 55. AnGes Revenue Growth Rate in Gene-based Advanced Therapy Medicinal Business (2018-2024)
Figure 56. Orchard Therapeutics Revenue Growth Rate in Gene-based Advanced Therapy Medicinal Business (2018-2024)
Figure 57. Human Stem Cells Institute Revenue Growth Rate in Gene-based Advanced Therapy Medicinal Business (2018-2024)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries